Germany Medical News

Quadratek Connect Ltd., has been chosen by ICRC-Weyer GmbH as the German CRO’s preferred partner for their social media management. This additional partnership enables Quadratek to strengthen its position within the clinical research industry.

The German contract research organization (CRO), ICRC-Weyer GmbH, has recently increased its efforts to deliver high-quality, expert medical data management services to the clinical research community.

This personal emergency pendant/dialer system features 2-way talk speakerphone capabilities and no monthly fees.

ICRC-Weyer GmbH, a contract research organisation (CRO) based in Berlin, Germany, has launched new corporate pages on the world’s leading social networks, Facebook and Google Plus, taking a pioneering role within the clinical research community.

The German based contract research organization, ICRC-Weyer GmbH, has adjusted its services portfolio in order to meet new requirements for the European nutrition market.

ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®.

The Arab Health '12 is set to create new benchmarks in the industry. The trade fair is a must attend for all prospective buyers and sellers in the medical industry, given the sheer volume of networking and trading opportunities: Global Citynews

The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This new healthcare app makes it possible to call up information about autoimmune diseases from a smartphone or tablet.

The highly sensitive Anti-CCP hs (high sensitive)® test makes possible the early diagnosis of rheumatoid arthritis (RA), which in turn allows for successful treatment of this autoimmune disease.

Aerotel’s latest version of Mobile-CliniQ™ application for Android platform to be presented together with other remote monitoring and mHealth solutions.

SMI Surgery Guidance™ Solution is Mature and Complete From Pre-Op Diagnostics to Post-Op Assessment

Complying with GLP regulations can increase the cost of a laboratory up to 30%. Companies or employees either don't know exactly what GLP really means, or what procedures are required and how to implement GLP regulations.

ORGENTEC has developed a new lab test for diagnosing autoimmune liver diseases. The immunoblot is suitable for initial and differential diagnosis in cases of ambiguous symptoms or for differentiation of a positive result from screening tests.

GXP Engaged Auditing Services, Munich, Germany, is a management buy-out of the QM consultancy/auditing brand of the Harrison Clinical Research Group. It provides assistance for the industry requiring full independence from other service providers.

GlobalData, the industry analysis specialist, has released its new report, Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017.

GlobalData, the industry analysis specialist, has released a new report, Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017.

Latest research from independent analyst, Business Insights, has assessed and documented the innovative drug discovery taking place in a corporate setting in countries that constitute emerging pharmaceutical markets, primarily: -

SMI Surgery Guidance for IOL now provides registration link to Haag Streit LENSTAR LS900 biometry device.

Especially in Asia breathing air enriched by the AIRNERGY-method is well appreciated. Inhabitants of overcrowded Asian cities describe the air that they breathe as becoming more and more visible.

BMI View: Singapore's healthcare sector is small, but will post steady growth over the next decade.

The FDA has approved Rituxan for first-line maintenance treatment of patients with advanced follicular lymphoma that responded to initial treatment with Rituxan plus chemotherapy.

Latest agreement brings together communities in the majority of key European markets

New analysis from Frost & Sullivan, Western European Markets for Peripheral Vascular Products, finds that overall market is set to expand.

The drug delivery devices market is set to reach $24.5 billion by 2015 according to latest research from independent market analyst, Business Insights.

On average, small molecule brands in the US experienced the greatest degree of brand erosion following patent expiry and exposure to direct generic competition, according to a new report from independent market analyst, Datamonitor.

The FDA has requested further Phase III trials of MannKind's inhaled insulin Afrezza with its next generation Dreamboat inhaler before it can be approved.

Biotech companies are increasingly seeking technology transfer arrangements because investor funding remains difficult to find as we emerge from the economic downturn, finds Business Insights.

GlobalData’s new report, External Defibrillators - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global external defibrillators market.

curasan AG has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone® Dental which already has been authorized in the EU as Osbone®

Grundig Business Systems (GBS), a world market leader in the field of professional dictation systems, is launching a new dictation model generation on the market, in February 2011.

Hennef, Germany (ots) – With immediate effect, Mrs. Susanne Klimpel, Medical Doctor specializing in clinic pharmacology is put in charge of the AIRNERGY AG Medical Management.

CROS DE lädt Sie ein, an einem deutschsprachigen Online-Seminar zum Thema Adaptive Trials teilzunehmen.

Smartphone penetration is the main driver for the growth of the mobile healthcare market. Lack of standardization, regulation and market opacity are the main barriers according to developers of mobile healthcare applications.

Meals are one of the few pleasant aspects of a stay in hospital - if they taste good. And TÜV NORD France is making sure that the service is as it should be in a 338-bed hospital in Corbie in Northern France.

GlobalData, the industry analysis specialist’s new report, Anti-Hypertension Therapeutics - Pipeline Assessment And Market Forecasts to 2017 is an essential source of information and analysis on the global hypertension market.

GBI Research’s report Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators provides in-depth analysis of the unmet needs, drivers and barriers that impact the global oral drug delivery market.

A global survey by research2guidance amongst leading mHealth developers and healthcare companies shows that mHealth apps will predominantly be distributed through traditional healthcare channels by 2015.

Integrated Modular Systems, Inc. (IMSI) and Grundig Business Systems (GBS) will be presenting a new voice product in combination with a GBS microphone at RSNA from November 28 until December 3.

Having issued a concept paper on the topic in October 2009, the European Medicines Agency has now confirmed that it is to publish its highly anticipated biosimilar monoclonal antibody development guidance in November 2010.

The brand-new SMI RED500 combines an unprecedented level of eye tracking performance with ease of use and integration into scientific experiments.

GBI Research, the leading business intelligence provider, has released its latest report, Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer -

GlobalData, the industry analysis specialist’s new report, Head and Neck Cancer – Pipeline Assessment and Market Forecast to 2017, is an essential source of information and analysis on the global head and neck cancer market.

Award winners for research studies in complementary medicine: Dr. Hernán Silván and Dr. Oxana Kirgizova.

GlobalData’s report, Stomach Cancer – Pipeline Assessment and Market Forecasts to 2017, is an essential source of information and analysis on the global stomach cancer market.

Due to safety concerns, sales of GlaxoSmithKline's Avandia will be suspended in Europe, while the FDA has restricted its availability. The drastic drop in sales that such measures will cause presents an opportunity for other drug classes to grow.

BMI View: The value of the global pharmaceutical market is forecast to increase from US$885bn in 2009 to US$911bn in 2010, equating to a year-on-year (y-o-y) growth rate of 2.90%.

Analysis from Frost & Sullivan, European Blood Pathogen Inactivation Market, finds the market generated revenues of about $238.5 in 2009 and estimates this to reach $521.5 million by 2013. This is early growth stage market with potential for growth.

GlobalData, the industry analysis specialist, has released its new report, Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Influenza Vaccines market.

Earlier in 2010, Medicines Australia negotiated a Memorandum of Understanding with the Labor government which was meant to provide stability for Australia's pharmaceutical industry.

At the 19th Congress of the European Academy of Dermatology and Venereology in Gothenburg, FotoFinder Systems GmbH presents the handyscope, a new device for mobile skin cancer examinations with the iPhone.